|
DCOY Decoy Therapeutics Inc 1615219 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,373,800.00 |
| Balance Sheet |
|
Current Assets
|
$8,573,308.00 |
|
Assets
|
$9,001,160.00 |
|
Current Liabilities
|
$4,680,254.00 |
|
Liabilities
|
$4,680,254.00 |
|
Equity
|
$4,320,906.00 |
|
Shares Out
|
531968.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,541,348.00 |
|
Investing Cash Flow
|
$-42,424.00 |
| Market Analysis |
Market Cap
|
$1,744,855.04 |
|
Price
|
$2.78 |
|
BVPS
|
8.12 |
|
PB
|
0.40 |
|
EPS
|
-4.46 |
|
FCF
|
$-6,118,348.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:54 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DCOY documents filed with the SEC.
DCOY Filings
Clear
